Studies disagree — unsettled
Sold almost entirely to one group of people — statin takers with aching muscles — on a mechanism that the trial which measured it directly could not find.
Solid lines are connections this site curates. Dashed lines mean the two ends share a research paper — worth knowing, and not a claim that one explains the other.
Statins can cause muscle symptoms, and muscle symptoms are the leading reason people stop taking a drug that was protecting their heart. rs4149056 in SLCO1B1 is the variant behind part of that — it affects how much statin reaches the liver rather than staying in the blood, and it is the one place in this subject where a genotype has real prescribing guidance behind it. See statin-associated muscle symptoms.
Coenzyme Q10 is what gets sold to those people. The reasoning: statins block a pathway that also produces CoQ10, CoQ10 is needed by mitochondria, muscles are full of mitochondria, so replacing it should help.
The trials disagree, and they have disagreed for twenty years. A 2025 meta-analysis of seven randomised trials in 389 patients found a significant reduction in muscle pain overall — a weighted mean difference of −0.96 (95% CI −1.88 to −0.03) — with four of the seven trials positive and three showing no change. That confidence interval nearly touches zero, and the authors said in so many words that more research is needed before evidence-based recommendations can be made.
The more awkward result is a 2022 trial that went and measured the mechanism. Thirty-seven people on simvastatin took 400 mg of CoQ10 or placebo for eight weeks, with muscle biopsies. CoQ10 in muscle did not rise. Mitochondrial respiratory capacity did not change. Myalgia did not improve, and individual changes in muscle CoQ10 did not track changes in pain.
So the honest position is the one this page is filed under: unsettled, leaning towards the story being better than the evidence. If the muscle symptoms are real enough that you are considering stopping a statin, the conversation worth having is with the prescriber — about the dose, the drug, and whether SLCO1B1 is relevant to you — rather than with a bottle.
Coenzyme Q10 is a compound the body makes and uses in mitochondria to produce cellular energy. It is sold mainly to people on statins who experience muscle aches, on the theory that statins deplete it.
The evidence disagrees. A 2025 meta-analysis of seven trials found a signal so close to zero it nearly crossed into no effect, and a 2022 trial that measured the mechanism directly found no change in muscle CoQ10, mitochondrial function, or pain.
Yes — unlike CoQ10, it is the one place in this subject where genotype has real prescribing guidance behind it, affecting how much statin reaches the liver.
Talk to the prescriber about the dose, the drug, and whether SLCO1B1 is relevant — that conversation is worth more than a bottle of CoQ10.
Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.
Coenzyme Q10. MyGeneLog™. https://www.mygenelog.com/supplements/coq10
Nothing on this page recommends taking anything. If a result here matters to you, take it to a doctor or a pharmacist rather than to a shop.